Fisetin: a multitarget flavonol bridging oxidative stress, inflammation, aging, and cancer
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-03 · 399 (6) · 7877-7899
DOI: 10.1007/s00210-025-04912-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 15.01.2026. Verfasst von Simerjeet Kaur Chahal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University Institute of Pharma Sciences, Chandigarh University, Gharuan, Mohali, Punjab, 140413, India. Hauptthemen laut MEDLINE: Flavonols, Flavonoids, Neoplasms, Aging. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 166 Literaturangaben.
Abstract (Originalsprache)
Fisetin is a naturally occurring dietary flavonoid that is abundant in fruits and vegetables such as strawberries, apples, and onions. It has gained significant scholarly attention owing to its broad pharmacological prospects. This compound exhibits robust antioxidant and anti-inflammatory activities and has notable anticancer and neuroprotective effects. Fisetin strongly modulates key cellular signaling pathways, induces apoptosis, and inhibits tumor growth, thus protecting cells against oxidative damage and neurodegenerative events. Additional hepatoprotective, antiviral, and gastroprotective actions further highlight the therapeutic importance of this compound. This review presents an integrated and detailed analysis of the pharmacokinetics, diverse biological activities, and molecular mechanisms of action of fisetin underlying its therapeutic actions. It also assesses its toxicological profile, including safety considerations such as genotoxicity at relatively high concentrations. Poor solubility and low bioavailability are key limitations, along with emerging formulation methods designed to facilitate its clinical utility. Furthermore, this review synthesizes evidence from ongoing trials and outlines future priorities. Collectively, these findings position fisetin as a promising therapeutic candidate with potential across a wide range of disease conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, University Institute of Pharma Sciences, Chandigarh University, Gharuan, Mohali, Punjab, 140413, India.
- Department of Pharmacology and Toxicology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
- Department of Pharmacology and Toxicology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia. m.ansari@psau.edu.sa.
Zitieren
APA
Chahal, S. K., Kabra, A., Saeedan, A. S., & Ansari, M. N. (2026). Fisetin: a multitarget flavonol bridging oxidative stress, inflammation, aging, and cancer. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(6), 7877-7899. https://doi.org/10.1007/s00210-025-04912-3
Vancouver
Chahal SK, Kabra A, Saeedan AS, Ansari MN. Fisetin: a multitarget flavonol bridging oxidative stress, inflammation, aging, and cancer. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(6):7877-7899. doi:10.1007/s00210-025-04912-3
BibTeX
@article{Chahal2026,
author = {Chahal, Simerjeet Kaur and Kabra, Atul and Saeedan, Abdulaziz S and Ansari, Mohd Nazam},
title = {Fisetin: a multitarget flavonol bridging oxidative stress, inflammation, aging, and cancer},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
volume = {399},
number = {6},
pages = {7877--7899},
doi = {10.1007/s00210-025-04912-3}
}
EUVIMED